Influence of diabetes on susceptibility to experimental pancreatic cancer
Authors:
- Patrick J. McCulloughPMPatrick J. McCullough
- Parviz M. PourPPParviz M. Pour
- 1 January 1988
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 155 (1) , 159-164
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Streptozotocin prevents development of nitrosamine‐induced pancreatic cancer in the syrian hamsterJournal of Surgical Oncology, 1983
- Animal models of diabetes mellitus: Physiology and pathologyJournal of Surgical Research, 1983
- Ductular origin of pancreatic cancer and its multiplicity in man comparable to experimentally induced tumors. A preliminary studyCancer Letters, 1979
- A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinomaDigestive Diseases and Sciences, 1978
- A Potent Pancreatic Carcinogen in Syrian Hamsters: N-Nitrosobis(2-oxopropyl)amine2JNCI: Journal of the National Cancer Institute, 1977
- Streptozotocin diabetes—further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liverBiochemical Pharmacology, 1973
- A case control study of cancer of the pancreasCancer, 1973
- The Association of Diabetes Mellitus with Primary Carcinoma of the PancreasActa Medica Scandinavica, 1960
- DIABETIC MORTALITY IN AUSTRALIAInternal Medicine Journal, 1958
- Diabetes and CancerNew England Journal of Medicine, 1934